Certest Diagnostics

From Immunodiagnostics to Molecular Diagnostics

Empowering laboratories worldwide with innovative diagnostic technologies designed to deliver accuracy, efficiency and confidence across every stage of the diagnostic journey.

With expertise spanning immunodiagnostics and molecular diagnostics, Certest provides laboratories and healthcare professionals with reliable solutions for routine testing, advanced analysis and high-complexity applications.

Two technologies. One diagnostic vision.

At Certest, our diagnostics portfolio is built around two complementary areas: Immunodiagnostics (IDx) and Molecular Diagnostics (MDx).

Together, these technologies support laboratories in delivering fast, reliable and actionable results, helping healthcare professionals make informed decisions with confidence. Whether through immunological detection methods or advanced molecular analysis, our solutions are developed to meet the evolving needs of modern diagnostics.

IDx Immunodiagnostics Solutions

Reliable immunodiagnostic technologies designed to support laboratories across a wide range of clinical settings.

Our IDx portfolio combines speed, automation and performance, enabling efficient workflows and dependable results from routine testing to high-throughput laboratory environments.

Rapid Test

Fast and accessible immunoassay solutions designed to support timely decision-making in laboratory and point-of-care settings.

CLIA

Automated chemiluminescence immunoassay technology delivering high sensitivity, scalability and operational efficiency for modern laboratories.

Turbidimetry

Quantitative immunoassay solutions developed for routine clinical laboratory workflows, providing reliable and reproducible results.

MDx Molecular Diagnostics Solutions

Advanced molecular technologies developed to provide highly sensitive and specific detection across a broad range of diagnostic applications.

Our MDx portfolio supports laboratories seeking precision, flexibility and innovation through molecular testing and genomic analysis.

Viasure

Comprehensive real-time PCR solutions designed to simplify workflows while delivering accurate and reliable molecular results.

NGS

Next-generation sequencing solutions supporting advanced genomic applications, research and future-ready diagnostic strategies.

Why Certest Diagnostics

Integrated Expertise

A complete diagnostics ecosystem combining immunodiagnostic and molecular technologies under one trusted partner.

Manufacturing Excellence

In-house development and manufacturing capabilities ensuring quality, consistency and supply reliability.

Global Reach

Supporting laboratories, distributors and healthcare organizations in more than 130 countries worldwide.

Regulatory Commitment

Strong expertise in international regulatory requirements and quality standards.

Scientific Support

Dedicated technical and scientific teams providing guidance throughout the customer journey.

Continuous Innovation

A long-term commitment to developing technologies that address the future needs of diagnostic laboratories.

Frequently Asked Questions

Immunodiagnostics (IDx) detects specific biomarkers through immunological reactions, while Molecular Diagnostics (MDx) identifies genetic material such as DNA or RNA for highly sensitive detection and analysis.

The IDx portfolio includes Rapid Test, CLIA and Turbidimetry technologies.

The MDx portfolio includes VIASURE Real-Time PCR and NGS solutions.

Certest solutions are distributed internationally through an extensive global network serving laboratories and healthcare organizations across more than 130 countries.

Yes. Our teams provide technical, scientific and regulatory support to help customers implement and maximize the value of our diagnostic solutions.

For information about distribution opportunities, please contact our team through the contact form.

Still have questions?

Our team is here to help. Contact us for more information about our diagnostic solutions, product availability or distribution opportunities.